BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38578628)

  • 1. Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs.
    Davey S; Costello K; Russo M; Davies S; Lalani HS; Kesselheim AS; Rome BN
    JAMA Health Forum; 2024 Apr; 5(4):e240302. PubMed ID: 38578628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis.
    Herink MC; Geddes J; Vo K; Zaman A; Hartung DM
    J Manag Care Spec Pharm; 2021 Jul; 27(7):856-864. PubMed ID: 34185560
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist.
    Nephew LD; Wang Y; Mohamed K; Nichols D; Rawl SM; Orman E; Desai AP; Patidar KR; Ghabril M; Chalasani N; Kasting ML
    J Viral Hepat; 2022 May; 29(5):366-374. PubMed ID: 35254695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications.
    Auty SG; Shafer PR; Griffith KN
    JAMA Health Forum; 2021 Aug; 2(8):e212291. PubMed ID: 35977192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C.
    Jiang X; Song HJ; Chang CY; Wilson D; Guo J; Lo-Ciganic WH; Park H
    Med Care; 2023 Feb; 61(2):81-86. PubMed ID: 36453625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
    Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
    JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.
    Auty SG; Shafer PR; Dusetzina SB; Griffith KN
    JAMA Health Forum; 2021 Aug; 2(8):e212285. PubMed ID: 35977199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
    Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
    Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
    Pham TT; Keast SL; Farmer KC; Thompson DM; Rathbun RC; Nesser NJ; Holderread BP; Skrepnek GH
    J Manag Care Spec Pharm; 2018 Jul; 24(7):664-676. PubMed ID: 29952711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.
    Thompson WW; Symum H; Sandul A; ; Gupta N; Patel P; Nelson N; Mermin J; Wester C
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1011-1017. PubMed ID: 35951484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
    Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
    JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C.
    Jiang X; Song HJ; Chang CY; Wilson DL; Lo-Ciganic WH; Park H
    Med Care; 2023 Aug; 61(8):505-513. PubMed ID: 37223993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.
    Lu CY; Zhang F; Golonski N; Lupton C; Jeffrey P; Wagner AK
    Value Health; 2018 Jun; 21(6):692-697. PubMed ID: 29909874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term budget affordability of hepatitis C treatments for state Medicaid programs.
    Chou JW; Silverstein AR; Goldman DP
    BMC Health Serv Res; 2019 Feb; 19(1):140. PubMed ID: 30819153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C.
    Park H; Song HJ; Jiang X; Henry L; Cook RL; Nelson DR
    Hepatol Commun; 2021 Feb; 5(2):203-216. PubMed ID: 33553969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?
    Du P; Wang X; Kong L; Jung J
    Telemed J E Health; 2021 May; 27(5):488-494. PubMed ID: 32882154
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
    Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J;
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):366-382. PubMed ID: 38367631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.
    Spradling PR; Xing J; Rupp LB; Moorman AC; Gordon SC; Lu M; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
    J Clin Gastroenterol; 2018 Aug; 52(7):641-647. PubMed ID: 28590325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.
    Epstein RL; Wang J; White LF; Kapadia SN; Morgan JR; Bao Y; Linas BP
    Am J Prev Med; 2022 Sep; 63(3):e87-e98. PubMed ID: 35725599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
    Kalidindi Y; Jung J; Feldman R; Riley T
    JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.